Trial intelligence / Profile preview

Physicians' Health Study

NCT00000500Phase 3Completed

Sponsor
Brigham and Women's Hospital
Start
Sep 1981
Primary completion
Dec 1995
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 3 trial of aspirin, beta-carotene in cardiovascular disease (CVD), cancer, sponsored by Brigham and Women's Hospital. Started Sep 1981; status: completed.

02

Drugs

aspirinbeta-carotene
03

Conditions

cardiovascular disease (CVD)cancer

Beyond the preview

Go deeper on NCT00000500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call